Younger, D.S. (2020) Post-Infectious Sequela of SARS-COV-2 Infection in Adults and Children: An Overview of Available Agents and Clinical Responsiveness. Arch Neurology and Neurological Disorder, 3, e102.

has been cited by the following article:

• TITLE: Immunotherapy for the Post-Infectious Sequela of SARS-CoV-2 Infection

  AUTHORS: David S. Younger

  KEYWORDS: SARS-CoV-2, Covid-19, Intravenous Immune Globulin, IVIg, Pediatric Multi-System Inflammatory Syndrome

  JOURNAL NAME: World Journal of Neuroscience, Vol.10 No.2, May 18, 2020

  ABSTRACT: The SARS-CoV-2 2019 pandemic is creating challenges to the management of post-infectious autoimmunity in childhood and adult Covid-19 cases due to its high case fatality. Nearly all of the agents envisioned to treat Covid-19 illness, including the newly recognized pediatric multi-system inflammatory syndrome, impact post-infectious mechanisms in keeping with the multiplier effect of infection, immunity and inflammation, known as I-Cubed (I3).